Maintaining genetic stability through TP53 mediated checkpoint control

Cancer Surveys

Volumn 29, Issue , 1997, Pages 183-219

  Wahl, G M ^a   Linke, S P ^a,b   Paulson, T G ^a,b   Huang, L C ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BASE MISPAIRING; CELL CYCLE; CHROMOSOME BREAKAGE; DNA BINDING; DNA DAMAGE; GENETIC STABILITY; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SIGNAL PROCESSING; TUMOR GROWTH;

DNA DAMAGE; FIBROBLASTS; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION; GENES, P53; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031003783     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (254)

1. Aaltonen LA, Peltomaki P, Leach FS et al (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260 812-816
2. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proceedings of the National Academy of Sciences of the USA 92 8493-8497
3. Allen JB, Zhou Z, Siede W, Friedberg EC and Elledge SJ (1994) The SAD1/RAD53 protein kinase controls multiple checkpoints and DNA damage-induced transcription in yeast. Genes and Development 8 2401-2415
4. Almasan A, Linke SP, Paulson TG, Huang L and Wahl GM (1995a) Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer and Metastasis Reviews 14 59-73
5. Almasan A, Yin Y, Kelly R et al (1995b) Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proceedings of the National Academy of Sciences of the USA 92 5436-5440
6. Anderson CW and Lees MS (1992) The nuclear serine/threonine protein kinase DNA-PK. Critical Reviews in Eukaryotic Gene Expression 2 283-314
7. Anthoneý DA, Mcllwrath AJ, Gallagher WM, Edlin AR and Brown R (1996) Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Research 56 1374-1381
8. Arlett GF, Green MH, Priestley A, Harcourt SA and Mayne LV (1988) Comparative human cellular radiosensitivity. I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. International journal of Radiation Biology 54 911-928
9. Bakalkin G, Yakovleva T, Selivanova G et al (1994) p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proceedings of the National Academy of Sciences of the USA 91 413-417
10. Barbet N and Carr A (1993) Fission yeast weel protein kinase is not required for DNA damage-dependent mitotic arrest. Nature 363 824-827
11. Barlow C, Hirotsune S, Paylor R et al (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia.Cell 86 159-171
12. Baylin SB (1992) Abnormal regional hypermethylation in cancer cells. AIDS Research and Human Retroviruses 8 811-820
13. Benner SE, Wahl GM and Von Hoff DD (1991) Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines. Anti-Cancer Drugs 2 11-25
14. Bennett CB, Lewis AL, Baldwin KK and Resnick MA (1993) Lethality induced by a single site-specific double-strand break in a dispensable yeast plasmid. Proceedings of the National Academy of Sciences of the USA 90 5613-5617
15. Bennett CB, Westmoreland TJ, Snipe JR and Resnick MA (1996) A double-strand break within a yeast artificial chromosome (YAC) containing human DNA can result in YAC loss, deletion, or cell lethality. Molecular and Cell Biology 16 4414-4425
16. Bhattacharyya NP, Skandalis A, Ganesh A, Groden J and Meuth M (1994) Mutator phenotypes in human colorectal carcinoma cell lines. Proceedings of the National Academy of Sciences of the USA 91 6319-6623
17. Biedermann KA, Sun JR, Giaccia AJ, Tosto LM and Brown JM (1991) seid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proceedings of the National Academy of Sciences of the USA 88 1394-1397
18. Blunt T, Finnie NJ, Taccioli GE et al (1995) Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine seid mutation. Cell 80 813-823
19. Bouffler SD, Kemp CJ, Balmain A and Cox R (1995) Spontaneous and ionizing radiation- induced chromosomal abnormalities in p53-deficient mice. Cancer Research 55 3883-3889
20. Boulikas T (1996) DNA lesion-recognizing proteins and the p53 connection. Anticancer Research 16 225-242
21. Bronner CE, Baker SM, Morrison PT et al (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368 258-261
22. Brown PC, Tlsty TD and Schimke RT (1983) Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea. Molecular and Cell Biology 3 1097-1107
23. Brush OS, Anderson CW and Kelly TJ (1994) The DNA-activated protein kinase is required for the phosphorylation of replication protein A during simian virus 40 DNA replication. Proceedings of the National Academy of Sciences of the USA 91 12520-12524
24. Carr AM and Hoekstra MF (1995) The cellular responses to DNA damage. Trends in Cell Biology 5 32-35
25. Chen CY, Oliner JD, Zhan Q, Fornace AJ, Vogelstein B and Kastan MB (1994) Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proceedings of the National Academy of Sciences of the USA 91 2684-2688
26. Chen J, Jackson PK, Kirschner MW and Dutta A (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374 386-388
27. Chowdary DR, Dermody JJ, Jha KK and Ozer HL (1994) Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Molecular and Cell Biology 14 1997-2003
28. Clarke AR, Purdie CA, Harrison DJ et al (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362 849-852
29. Clarke AR, Gledhill S, Hooper ML, Bird CC and Wyllie AH (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 9 1767-1773
30. Cleaver JE (1989) DNA repair in man. Birth Defects 25 61-82
31. Cleaver JE (1994) It was a very good year for DNA repair. Cell 76 1-4
32. Cornforth MN and Bedford JS (1985) On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science 227 1589-1591
33. Cornforth MN and Bedford JS (1987) A quantitative comparison of potentially lethal damage repair and the rejoining of interphase chromosome breaks in low passage normal human fibroblasts. Radiation Research 111 385-405
34. Cornforth MN and Goodwin EH (1991) The dose-dependent fragmentation of chromatin in human fibroblasts by 3.5-MeV alpha particles from 238Pu: experimental and theoretical considerations pertaining to single-track effects. Radiation Research 127 64-74
35. Cross SM, Sanchez CA, Morgan CA et al (1995) A p53-dependent mouse spindle checkpoint. Science 267 1353-1356
36. Dameron KM, Volpert OV, Tainsky MA and Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265 1582-1584
37. 1 cyclin-dependent kinase activity. Genes and Development 9 2873-2887
38. 1 checkpoint control. Cell 82 675-684
39. Denko N, Stringer J, Wani M and Stambrook P (1995) Mitotic and post mitotic consequences of genomic instability induced by oncogenic Ha-ras. Somatic Cell and Molecular Genetics 21 241-253
40. de Oca Luna RM, Wagner DS and Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378 203-206
41. Devary Y, Gottlieb RA, Smeal T and Karin M (1992) The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71 1081-1091
42. Devary Y, Rosette C, DiDonato JA and Karin M (1993) NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261 1442-1445
43. Di Leonardo A, Linke SP, Yin Y and Wahl GM (1993) Cell cycle regulation of gene amplification. Cold Spring Harbor Symposia on Quantitative Biology 58 655-667
44. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes and Development 8 2540-2551
45. Donehower LA and Bradley A (1993) The tumor suppressor p53. Biochimica et Biophysica Acta 1155 181-205
46. Donehower LA, Harvey M, Slagle BL et al (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 215-221
47. Donehower LA, Godley LA, Aldaz CM et al (1995) Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes and Development 9 882-895
48. Dover R, Jayaram Y, Patel K and Chinery R (1994) p53 expression in cultured cells following radioisotope labelling. Journal of Cell Science 107 1181-1184
49. Dulbecco R (1989) Cancer progression: the ultimate challenge. International Journal of Cancer 4 (Supplement 6) 6-9
50. 1 arrest. Cell 76 1013-1023
51. Dutta A, Ruppert M, Aster J and Winchester E (1993) Inhibition of DNA replication factor by p53. Nature 365 79-82
52. Dynlacht BD, Flores O, Lees JA and Harlow E (1994) Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes and Development 8 1772-1786
53. Eckhardt SG, Dai A, Davidson KK, Forseth BJ, Wahl GM and Von Hoff DD (1994) Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc. Proceedings of the National Academy of Sciences of the USA 91 6674-6678
54. Enoch T, Carr AM and Nurse P (1992) Fission yeast genes involved in coupling mitosis to completion of DNA replication. Genes and Development 6 2035-2046
55. Eshleman JR, Lang EZ, Bowerfind GK et al (1995) Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene 10 33-37
56. Fagan R, Flint KJ and Jones N (1994) Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell 78 799-811
57. Farnham PJ, Slansky JE and Kollmar R (1993) The role of E2F in the mammalian cell cycle. Biochimica et Biophysica Acta 1155 125-131
58. Fiscella M, Ullrich SJ, Zambrano N et al (1993) Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 8 1519-1528
59. Fiscella M, Zambrano N, Ullrich SJ et al (1994) The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Oncogene 9 3249-3257
60. Fishel R and Kolodner RD (1995) Identification of mismatch repair genes and their role in the development of cancer. Current Current Opinion in Genetics and Development 5 382-395
61. Fishel R, Lescoe MK, Rao MR et al (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75 1027-1038
62. Flintoff WF, Davidson SV and Siminovitch L (1984) Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells. Somatic Cell and Molecular Genetics 2 245-261
63. Fontoura BM, Sorokina EA, David E and Carroll RB (1992) p53 is covalently linked to 5.8S rRNA. Molecular and Cell Biology 12 5145-5151
64. Ford JM and Hanawalt PC (1995) Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proceedings of the National Academy of Sciences of the USA 92 8876-8880
65. Fornace AJ, Nagasawa H and Little JB (1980) Relationship of DNA repair to chromosome aber- rations, sister-chromatid exchanges and survival during liquid-holding recovery in X- irradiated mammalian cells. Mutation Research 70 323-336
66. Friedberg EC, Walker GC and Siede W (eds) (1995) DNA Repair and Mutagenesis, ASM Press, Washington, DC
67. Fuchs B, O'Connor D, Fallis L, Scheidtmann KH and Lu X (1995) p53 phosphorylation mutants retain transcription activity. Oncogene 10 789-793
68. Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF (1996) Abnormal centro-some amplification in the absence of p53. Science 271 1744-1747
69. Girinsky T, Koumenis C, Graeber TG, Peehl DM and Giaccia AJ (1995) Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA- damaging agents. Cancer Research 55 3726-3731
70. Giulotto E, Knights G and Stark GR (1987) Hamster cells with increased rates of DNA amplification: a new phenotype. Cell 48 837-845
71. Glebov OK, McKenzie KE, White CA and Sukumar S (1994) Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Research 54 3703-3709
72. 1 phase of the cell cycle. Cell 67 293-302
73. Gottlieb TM and Jackson SP (1993) The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 72 131-142
74. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Molecular and Cell Biology 14 6264-6277
75. Graeber TG, Osmanian C, Jacks T et al (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 88-91
76. 1-phase checkpoint. Radiation Research 145 289-298
77. Hainaut P (1995) The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Current Opinion in Oncology 7 76-82
78. Hainaut P and Milner J (1993a) Redox modulation of p53 conformation and sequence-specific DNA binding. Cancer Research 53 4469-4473
79. Hainaut P and Milner J (1993b) A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Research 53 1739-1742
80. Hainaut P, Rolley N, Davies M and Milner J (1995) Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene 10 27-32
81. Harrington J, Hsieh CL, Gerton J, Bosma G and Lieber MR (1992) Analysis of the defect in DNA end joining in the murine scid mutation. Molecular and Cell Biology 12 4758-4768
82. Hartwell LH and Kastan MB (1994) Cell cycle control and cancer. Science 266 1821-1828
83. Hartwell LH and Weinert TA (1989) Checkpoints: controls that ensure the order of cell cycle events. Science 246 629-634
84. Harvey M, Sands A, Weiss R et al (1993) In vitro growth characteristics of embryo fibroblasts is- lolated from p53-deficient mice. Oncogene 8 2457-2467
85. 2 cell cycle checkpoint. Cancer Research 55 3721-3725
86. Hendrickson EA, Qin XQ, Bump EA, Schatz DG, Oettinger M and Weaver DT (1991) A link between double-strand break-related repair and V(D)J recombination: the scid mutation. Proceedings of the National Academy of Sciences of the USA 88 4061-4065
87. Herman JG, Merlo A, Mao L et al (1995) Inactivation of the CDKN2/pl6/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research 55 4525-4530
88. Herman JG, Jen J, Merlo A and Baylin SB (1996) Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Research 56 722-727
89. 1 restriction point regulation in Rb-deficient fibroblasts. Molecular and Cell Biology 16 2402-2407
90. Hoyt MA, Totis L and Roberts BT (1991) S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66 507-517
91. Huang JC, Svoboda DL, Reardon JT and Sancar A (1992) Human nucleotide excision nuclease removes thymine dinners from DNA by incising the 22nd phosphodiester bond 5′ and the 6th phosphodiester bond 3′ to the photodimer. Proceedings of the National Academy of Sciences of the USA 89 3664-3668
92. Huang L-C, Clarkin KC and Wahl GM (1996a) p53 dependent cell cycle arrests are preserved in DNA-activated protein kinase deficient mouse fibroblasts. Cancer Research 56 2940- 2944
93. Huang L-C, Clarkin KC and Wahl GM (1996b) Sensitivity and selectivity of the p53-mediated DNA damage sensor. Proceedings of the National Academy of Sciences of the USA 93 4827- 4832
94. Hupp TR and Lane DP (1995) Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner, Journal of Biological Chemistry 270 18165-18174
95. Hupp TR, Meek DW, Midgley CA and Lane DP (1992) Regulation of the specific DNA binding function of p53. Cell 71 875-886
96. Hupp TR, Meek DW, Midgley CA and Lane DP (1993) Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Research 21 3167-3174
97. Hupp TR, Sparks A and Lane DP (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83 237-245
98. Iliakis G (1988) Radiation-induced potentially lethal damage: DNA lesions susceptible to fixation. International Journal of Radiation Biology and Related Studies in Physics, Chemical and Medicine 53 541-584
99. Ionov Y, Peinado MA, Mulkhosyan S, Shibata D and Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic car- cinogenesis. Nature 363 558-561
100. Ishizaka Y, Chernov M, Burns C and Stark G (1995) p53-dependent growth arrest of REF52 cells containing newly amplified DNA. Proceedings of the National Academy of Sciences of the USA 92 3224-3228
101. Issa JP and Baylin SB (1996) Epigenetics and human disease. Nature Medicine 2 281-282
102. Jayaraman J and Prives G (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81 1021-1029
103. Johnson DG, Schwarz JK, Cress WD and Nevins JR (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365 349-352
104. Jones SN, Roe AE, Donehower LA and Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378 206-208
105. Jones SN, Sands AT, Hancock AR et al (1996) Absence of a p53-independent role for Mdm2 in control of cell growth and tumorigenesis. Proceedings of the National Academy of Sciences of the USA 93 14106-14111
106. Kadyk LC and Hartwell LH (1992) Sister chromatids are preferred over homologs as substrates for recombinational repair in Saccharomyces cerevisiae. Genetics 132 387-402
107. Kallioniemi A, Kallioniemi OP, Sudar D et al (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 818-821
108. Kallioniemi O-P, Kallioniemi A, Chen L-C et al (1993) DNA amplification in primary breast cancer detected by comparative genomic hybridization. Proceedings of the American Association for Cancer Research 34 500
109. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Research 51 6304-6311
110. Kastan MB, Zhan Q, El-Deiry WS et al (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71 587-597
111. Kaufmann WK (1995) Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer and Metastasis Reviews 14 31-41
112. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ and Look AT (1993) Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Research 53 5535-5541
113. Kim C, Snyder RO and Wold MS (1992) Binding properties of replication protein A from human and yeast cells. Molecular and Cell Biology 12 3050-3059
114. Kirchgessner CU, Patil CK, Evans JW et al (1995) DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267 1178-1183
115. Ko LJ and Prives C (1996) p53: puzzle and paradigm. Genes and Development 10 1054-1072
116. Kolodner R (1996) Biochemistry and genetics of eukaryotic mismatch repair. Genes and Development 10 1433-1442
117. Kuo MT, Vyas RC, Jiang LX and Hittelman WN (1994) Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Molecular and Cell Biology 14 5202-5211
118. Lane DP (1992) p53, guardian of the genome. Nature 358 15-16
119. Leach FS, Nicolaides NC, Papadopoulos N et al (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75 1215-1225
120. Lee JM and Bernstein A (1993) p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences of the USA 90 5742-5746
121. Lee JM, Abrahamson JL, Kandel R, Donehower LA and Bernstein A (1994) Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 9 3731-3736
122. Lee S, Elenbaas B, Levine A and Griffith J (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81 1013-1020
123. Lees-Miller S, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW (1992) Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Molecular and Cell Biology 12 5041-5049
124. Levine AJ, Momand J and Finlay CA (1991) The p53 tumour suppressor gene. Nature 351 453-456
125. 1 arrest in established human tumor cell lines. Oncogene 11 1885-1892
126. Li CY, Nagasawa H, Tsang NM and Little JB (1995b) Radiation-induced irreversible G(0)/G(1) block is abolished in human diploid fibroblasts transfected with the human papilloma virus E6 gene: implication of the p53-Cip1/WAF1 pathway. International Journal of of Oncology 6 233-236
127. Li R and Murray AW (1991) Feedback control of mitosis in budding yeast. Cell 66 519-531
128. Li W, Fan J, Hochhauser D et al (1995c) Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proceedings of the National Academy of Sciences of the USA 92 10436-10440
129. 1 phase. Proceedings of the National Academy of Sciences of the USA 89 9210-9214
130. 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes and Development 10 934-947
131. Linke SP, Clarkin KG and Wahl GM p53 mediates permanent arrest over multiple cell cycle in response to y radiation. Cander Research (in press)
132. Little JB (1969) Repair of sub-lethal and potentially lethal radiation damage in plateau phase cultures of human cells. Nature 224 804-806
133. Little JB (1994) Changing views of cellular radiosensitivity. Radiation Research 140 299-311
134. Little JB and Nagasawa H (1985) Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia- telangiectasia fibroblasts. Radiation Research 101 81-93
135. Little JB, Nove J, Strong LC and Nichols WW (1988) Survival of human diploid skin fibroblasts from normal individuals after X-irradiation. International Journal of Radiation Biology 54 899-910
136. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70 923-935
137. Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Research 51 3075-3079
138. Lonn U, Lonn S, Nilsson B and Stenkvist B (1996) Higher frequency of gene amplification in breast cancer patients who received adjuvant chemotherapy. Cancer 77 107-112 Lowe SW.
139. LoweSW, Ruley HE, Jacks T and Housman DE (1993a) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74 957-967
140. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993b) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362 847-849
141. Lu X and Lane DP (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75 765-778
142. Ma C, Martin S, Trask B and Hamlin JL (1993) Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. Genes and Development 7 605- 620
143. McClintock B (1984) The significance of responses of the genome to challenge. Science 226 792-801
144. McIlwrath AJ, Vasey PA, Ross GM and Brown R (1994) Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Research 54 3718-3722
145. Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B and Baylin SB (1992) Distinct hyper- methylation patterns occur at altered chromosome loci in human lung and colon cancer. Proceedings of the National Academy of Sciences of the USA 89 1929-1933
146. Makos M, Nelkin BD, Reiter RE et al (1993) Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Research 53 2719-2722
147. Malkin D, Li F, Strong LC et al (1990) Germ line p53 mutations in a familial syndrome of sarcomas, breast cancer and other neoplasms. Science 250 1233-1238
148. Marchese MJ, Zaider M and Hall EJ (1987) Dose-rate effects in normal and malignant cells of human origin. British Journal of Radiology 60 573-576
149. Marder BA and Morgan WF (1993) Delayed chromosomal instability induced by DNA damage. Molecular and Cell Biology 13 6667-6677
150. Marechal V, Elenbaas B, Piette J, Nicolas JC and Levine AJ (1994) The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Molecular and Cell Biology 14 7414- 7420
151. Markowitz S, Wang J, Myeroff L et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268 1336-1338
152. Marra C and Boland CR (1995) Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. Journal of the National Cancer Institute 87 1114-1125
153. Merlo A, Mabry M, Gabrielson E, Vollmer R, Baylin SB and Sidransky D (1994) Frequent mi- crosatellite instability in primary small cell lung cancer. Cancer Research 54 2098-2101
154. Merlo A, Herman JG, Mao L et al (1995) 5′ CpG island methylation is associated with tran- scriptional silencing of the tumour suppressor pl6/CDKN2/MTS1 in human cancers. Nature Medicine 1 686-692
155. Miller R, Hogg J, Ozaki J, Gell D, Jackson S and Riblet R (1995) The gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proceedings of the National Academy of Sciences of the USA 92 10792-10795
156. Milner J (1991) A conformation hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer. Proceedings of the Royal Society of London B 245 139-145
157. Milner J (1994) Forms and functions of p53. Seminars in Cancer Biology 5 211-219
158. Milner J (1995) Flexibility: the key to p53 function? Trends in Biochemical Sciences 20 49-51
159. Mimori T, Hardin JA and Steitz JA (1986) Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. Journal of Biological Chemistry 261 2274-2278
160. Minaschek G, Bereiter-Hahn J and Berthholdt G (1989) Quantitation of the volume of liquid injected into cells by means of pressure. Experimental and Cell Research 183 434-442
161. Modrich P (1991) Mechanisms and biological effects of mismatch repair. Annual Reviews of Genetics 25 229-253
162. Momand J, Zambetti G, Olson D, George D and Levine A (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69 1237-1245
163. Mummenbrauer T, Janus F, Muller B, Wiesmuller L, Deppert W and Grosse F (1996) p53 protein exhibits 3′ -to-5′ exonuclease activity. Cell 85 1089-1099
164. Nagasawa H and Little JB (1983) Comparison of kinetics of X-ray-induced cell killing in normal, ataxia telangiectasia and hereditary retinoblastoma fibroblasts. Mutation Research 109 297-308
165. Nagasawa H, Robertson JB, Arundel CS and Little JB (1984) The effect of X irradiation on the progression of mouse 10T1/2 cells released from density-inhibited cultures. Radiation Research 97 537-545
166. Nagasawa H, Little JB, Tsang NM, Saunders E, Tesmer J and Strniste GF (1992) Effect of dose rate on the survival of irradiated human skin fibroblasts. Radiation Research 132 375-379
167. 1 phase arrest and p53 function in human tumor cells. Cancer Research 55 1842-1846
168. Navas TA, Zhou Z and Elledge SJ (1995) DNA polymerase epsilon links the DNA replication machinery to the S phase checkpoint. Cell 80 29-39
169. Nelson WG and Kastan MB (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Molecular and Cell Biology 14 1815-1823
170. Nishino H, Knoll A, Buettner VL et al (1995) p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. Oncogene 11 263-270
171. Norimura T, Nomoto S, Katsuki M, Gondo Y and Kondo S (1996) p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nature Medicine 2 577-580
172. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194 23-28
173. Nowell PC (1982) Genetic instability in cancer cells: relationship to tumor cell heterogeneity, In: Owens AH Jr, Coffey DS and Baylin SB (eds). Tumor Cell Heterogeneity: Origins and Implications, pp 351-365, Academic Press, New York
174. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362 857-860
175. O'Neill EM, Kaffman A, Jolly ER and O'Shea EK (1996) Regulation of PHO4 nuclear localization by the PHO80-PHO85 cyclin-CDK complex. Science 271 209-212
176. Palace GP and Lawrence DA (1995) Nucleotide changes in oxidatively stressed lymphocytes. Journal of Biochemical Toxicology 10 137-142
177. Pandita TK and Hittelman WN (1992) The contribution of DNA and chromosome repair deficiencies to the radiosensitivity of ataxia-telangiectasia. Radiation Research 131 214-223
178. 1 events and regulation of cell proliferation. Science 246 603
179. Patel U, Grundfest BS, Gupta M and Banerjee S (1994) Microsatellite instabilities at five chromosomes in primary breast tumors. Oncogene 9 3695-700
180. 2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Research 55 1763-1773
181. Paulovich AC and Hartwell LH (1995) A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell 82 841-847
182. Paulson TG, Wright FA, Parker BA, Russack V and Wahl GM (1996) Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Research 56 4021-4026
183. Peltomaki P, Lothe RA, Aaltonen LA et al (1993) Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Research 53 5853-5855
184. Perry ME, Rolfe M, Mclntyre P, Commane M and Stark GR (1992) Induction of gene amplification by 5-aza-2′ -deoxycytidine. Mutation Research 276 189-197
185. Phipps J, Nasim A and Miller DR (1985) Recovery, repair, and mutagenesis in Schizosaccharomyces pombe. Advances in Genetics 23 1-72
186. Pietenpol J and Vogelstein B (1993) No room at the p53 inn. Nature 365 17-18
187. Reifenberger G, Liu L, Ichimura K, Schmidt EE and Collins VP (1993) Amplification and over-expression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Research 53 2736-2739
188. Renzing J and Lane DP (1995) p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts. Oncogene 10 1865-1868
189. Rhyu MG, Park WS and Meltzer SJ (1994) Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 9 29-32
190. Rowley JD (1990a) Molecular cytogenetics: Rosetta stone for understanding cancer. Cancer Research 50 3816-3825
191. Rowley JD (1990b) Recurring chromosome abnormalities in leukemia and lymphoma. Seminars in Hematology 27 122-136
192. Russo CA, Weber TK, Volpe CM et al (1995) An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer. Cancer Research 55 1122-1128
193. Samad A and Carroll RB (1991) The tumor suppressor p53 is bound to RNA by a stable covalent linkage. Molecular and Cell Biology 11 1598-1606
194. Sandell LL and Zakian VA (1993) Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 75 729-739
195. Sands AT, Suraokar MB, Sanchez A, Marth JE, Donehower LA and Bradley A (1995) p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proceedings of the National Academy of Sciences of the USA 92 8517-8521
196. Savitsky K, Bar-Shira A, Gilad S et al (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268 1749-1753
197. Schaefer DI, Livanos EM, White AE and Tlsty TD (1993) Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts. Cancer Research 53 4946-4951
198. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.Cell 63 1129-1136
199. Scheffner M, Huibregtse JM, Vierstra RD and Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75 495-505
200. Schorpp M, Mallick U, Rahmsdorf H and Herrlich P (1984) UV-induced extracellular factor from human fibroblasts communicates the UV response to nonirradiated cells. Cell 37 861-868
201. Schwartz JL (1992) The radiosensitivity of the chromosomes of the cells of human squamous cell carcinoma cell lines. Radiation Research 129 96-101
202. Schwartz JL and Vaughan AT (1989) Association among DNA/chromosome break rejoining rates, chromatin structure alterations, and radiation sensitivity in human tumor cell lines. Cancer Research 49 5054-5057
203. Sen P and Hittelman WN (1984) Kinetics and extent of repair of bleomycin-induced chromosome damage in quiescent normal human fibroblasts and human mononuclear blood cells. Cancer Research 44 591-596
204. Shay JW, Tomlinson G, Piatyszek MA and Gollahon LS (1995) Spontaneous in vitro immortalization of breast epithelial cells from a Li-Fraumeni patient. Molecular and Cell Biology 15 425-432
205. Shimizu N, Nakamura H, Kadota T et al (1994) Loss of amplified c-myc genes in the spontaneously differentiated HL-60 cells. Cancer Research 54 3561-3567
206. Shridhar V, Siegfried J, Hunt J et al (1994) Genetic instability of microsatellite sequences in many non-small cell lung carcinomas. Cancer Research 54 2084-2087
207. 1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proceedings of the National Academy of Sciences of the USA 91 5320-5324
208. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Research 53 4164-4168
209. Smith KA, Gorman PA, Stark MB, Groves RP and Stark GR (1990) Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell 63 1219-1227
210. Smith KA, Stark MB, Gorman PA and Stark GR (1992) Fusions near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells. Proceedings of the National Academy of Sciences of the USA 89 5427-5431
211. Smith ML, Chen IT, Zhan Q et al (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266 1376-1380
212. Smith KA, Agarwal ML, Chernov MV et al (1995a) Regulation and mechanisms of gene amplification. Philosophical Transactions of the Royal Society B 347 49-56
213. Smith ML, Chen IT, Zhan Q, O'Connor PM and Fornace AJ (1995b) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10 1053-1059
214. Soussi T, Caron de Fromentel C and May P (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5 945-952
215. Srivastava S, Zou Z, Pirollo K, Blattner W and Chang EH (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348 747- 749
216. 2/M by p53. Oncogene 10 109-115
217. Stopper H, Korber C, Schiffmann D and Caspary WJ (1993) Cell-cycle dependent micronucleus formation and mitotic disturbances induced by 5-azacytidine in mammalian cells. Mutation Research 300 165-177
218. Sturzbecher H-W, Donzelmann B, Henning W, Knippschild U and Buchhop S (1996) p53 is linked directly to homologous recombination processes via RAD51/recA protein interaction. EMBO Journal 15 1992-2002
219. Su LN and Little JB (1992) Transformation and radiosensitiviry of human diploid skin fibroblasts transfected with SV40 T-antigen mutants defective in RB and P53 binding domains. International Journal of Radiation Biology 62 461-468
220. Symonds H, Krall L, Remington L et al (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78 703-711
221. Tlsty TD (1990) Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proceedings of the National Academy of Sciences of the USA 87 3132-3136
222. Tlsty TD, Brown PC and Schimke RT (1984) UV radiation facilitates methotrexate resistance and amplification of the dihydrofolate reductase gene in cultured 3T6 mouse cells. Molecular and Cell Biology 4 1050-1056
223. Tlsty TD, Margolin BH and Lum K (1989) Differences in the rates of gene amplification in non-tumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proceedings of the National Academy of Sciences of the USA 86 9441-9445
224. Toledo F, Smith KA, Buttin G and Debatisse M (1992) The evolution of the amplified adenylate deaminase 2 domains in Chinese hamster cells suggests the sequential operation of different mechanisms of DNA amplification. Mutation Research 276 261-273
225. Tsang NM, Nagasawa H, Li C and Little JB (1995) Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene 10 2403-2408
226. Tuteja N, Tuteja R, Ochem A et al (1994) Human DNA helicase II: a novel DNA unwinding enzyme identified as the Ku autoantigen. EMBO Journal 13 4991-5001
227. Uchida T, Wada C, Wang C, Egawa S, Ohtani H and Koshiba K (1994) Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. Cancer Research 54 3682-2685
228. Van Meir EG, Polverini PJ, Chazin VR, Su HH, de Tribolet N and Cavenee WK (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genetics 8 171-176
229. Vertino PM, Spillare EA, Harris CC and Baylin SB (1993) Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells. Cancer Research 53 1684-1689
230. Visakorpi T, Kallioniemi AH, Syvanen AC et al (1995) Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Research 55 342-347
231. Von Hoff DD, McGill JR, Forseth BJ et al (1992) Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proceedings of the National Academy of Sciences of the USA 89 8165-8169
232. 2/M arrest and apoptosis. Nature Medicine 2 72-79
233. Wang XW, Yeh H Schaeffer L et al (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genetics 10 188-195
234. Wang XW, Vermeulen W, Coursen JD et al (1996) The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes and Development 10 1219-1232
235. Wani MA, Xu X and Stambrook PJ (1994) Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells. Cancer Research 54 2504-2508
236. Ward JF (1988) DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Progress in Nucleic Acid Research and Molecular Biology, 35 95-125, Academic Press, New York
237. Weinert TA and Hartwell LH (1988) The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241 317-322
238. Weinert TA, Kiser GL and Hartwell LH (1994) Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes and Development 8 652-665
239. Wilcock D and Lane DP (1991) Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature 349 429-431
240. Windle B, Draper BW, Yin YX, O'Gorman S and Wahl GM (1991) A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes and Development 5 160-174
241. Wlodek D and Hittelman WN (1988) The relationship of DNA and chromosome damage to survival of synchronized X-irradiated L5178Y cells. II. Repair. Radiation Research 115 566-575
242. Wooster R, Cleton-Jansen AM, Collins N et al (1994) Instability of short tandem repeats (microsatellites) in human cancers. Nature Genetics 6 152-156
243. Wright JA, Chan AK, Choy BK, Hurta RA, McClarty GA and Tagger AY (1990a) Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis. Biochemistry and Cell Bioligy 68 1364-1371
244. Wright JA, Smith HS, Watt FM, Hancock MC, Hudson DL and Stark GR (1990b) DNA amplification is rare in normal human cells. Proceedings of the National Academy of Sciences of the USA 87 1791-1795
245. Wu X, Bayle JH, Olson D and Levine AJ (1993) The p53-mdm-2 autoregulatory feedback loop. Genes and Development 7 1126-1132
246. Xu M, Sheppard KA, Peng CY, Yee AS and Piwnica WH (1994) Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Molecular and Cell Biology 14 8420-8431
247. Yeargin J and Haas M (1995) Elevated levels of wild-type p53 induced by radiolabeling of cells leads to apoptosis or sustained growth arrest. Current Biology 5 423-431
248. Yee CJ, Roodi N, Verrier CS and Parl FF (1994) Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Research 54 1641-1644
249. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70 937- 948
250. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M (1991) Wild-type p5 3 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 353 345-347
251. Yonish-Rouach E, Grunwald D, Wilder S et al (1993) p53-mediated cell death: relationship to cell cycle control. Molecular and Cell Biology 13 1415-1423
252. Yount GL, Haas KD, Vidair CA, Haas M, Dewey WC and Israel MA (1996) Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Research 56 500-506
253. Zhan Q, Carrier F and Fornace AJ (1993) Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Molecular and Cell Biology 13 4242-4250
254. Ziegler A, Jonason AS, Leffell DJ et al (1994) Sunburn and p53 in the onset of skin cancer. Nature 372 773-776